181例高分级动脉瘤性蛛网膜下腔出血患者术前再出血的影响因素

doi:10.6040/j.issn.1671-7554.0.2022.1378

摘要/Abstract

摘要： 目的探讨高分级动脉瘤性蛛网膜下腔出血(aSAH)患者术前再出血的影响因素。方法本研究为回顾性队列研究,共纳入181例符合世界神经外科学会联合会(WFNS)IV级和V级的aSAH患者。所有患者根据在治疗前有无再出血分为再出血组(n=26)和未再出血组(n=155)。采用病例-对照研究分析方法,分析比较两组患者的人口统计学特征、病史、临床状况、WFNS分级、CT Fisher分级、动脉瘤特征、治疗时间及6个月时的预后有关联的影响因素。结果 181例中有26例术前再出血。再出血组和未再出血组的性别、年龄、既往史(高血压、糖尿病、肥胖)、个人史(吸烟、酗酒)、临床状况(脑疝、脑内血肿、低密度区、脑积水)和放射学特征(动脉瘤位置、动脉瘤大小、多发动脉瘤)的差异均无统计学意义。再出血组中脑室内出血(IVH)13例,WFNS分级V级15例,CT Fisher分级3~4级25例,与未再出血组相比差异均有统计学意义。多因素分析表明,脑室内出血(OR=3.804,95%CI:1.161~12.462,P=0.027)为再出血的独立危险因素。再出血组预后不良(mRS 3~6分)20例(76.92%),死亡率26.9%,与未再出血组相比差异有统计学意义,再出血组的预后不良。结论 IVH、WFNS V级和CT Fisher 3~4级与术前再出血相关。人口统计学特征、病史、临床状况、患者治疗时间、脑室外引流和动脉瘤特征与术前再出血无显著相关性。

关键词: 颅内动脉瘤, 蛛网膜下腔出血, 再出血, 影响因素

Abstract: Objective To investigate the influencing factors of rebleeding in patients with poor-grade aneurysmal subarachnoid hemorrhage(aSAH). Methods A total of 181 patients who met the World Federation of Neurosurgical Societies(WFNS)grade IV or V criteria were enrolled in this retrospective cohort study. The patients were divided into rebleeding group(n=26)and non-rebleeding group(n=155). Case-control study analysis was used to compare the demographic characteristics, medical history, clinical status, WFNS grade, CT Fisher grade, aneurysm characteristics, treatment timing and outcomes at 6 months between the two groups. Results Preoperative relleeding was observed in 26 of 181 cases. There were no significant statistical differences between the two groups in gender, age, medical history(hypertension, diabetes and obesity), personal history(smoking and drinking), clinical status(cerebral hernia, intracerebral hematoma, low density area and hydrocephalus)and radiological characteristics(aneurysm location, aneurysm size, multiple aneurysms). In the rebleeding group, 13 cases had intraventricular hemorrhage, 15 cases were of WFNS grade V, 25 cases were of CT Fisher grade 3-4, and the differences were statistically significant compared with those in the non-rebleeding group. Multivariate analysis showed that intraventricular hemorrhage(OR=3.804, 95%CI: 1.161-12.462, P=0.027)was an independent risk factor for rebleeding. In the rebleeding group, 20 cases(76.92%)had poor prognosis(mRS 3-6), and the mortality rate was 26.9%. The difference was statistically significant compared with that in the non-rebleeding group. Unfavorable outcomes occurred more often in the rebleeding group. Conclusion IVH, WFNS grade V and CT Fisher grade 3-4 are associated with rebleeding. Demographic characteristics, medical history, clinical status, treatment timing, external ventricular drainage(EVD)or aneurysm characteristics are not significantly associated with rebleeding.

Key words: Intracranial aneurysm, Subarachnoid hemorrhage, Rebleeding, Influencing factors

中图分类号:

R651

胥凯,韩超,丁守銮,丁璇,邢德广,王成伟. 181例高分级动脉瘤性蛛网膜下腔出血患者术前再出血的影响因素[J]. 山东大学学报 (医学版), 2022, 60(9): 97-101.

XU Kai, HAN Chao, DING Shouluan, DING Xuan, XING Deguang, WANG Chengwei. Factors of preoperative rebleeding in 181 patients with poor-grade aneurysmal subarachnoid hemorrhage[J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 97-101.

参考文献

[1] Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage[J]. Stroke, 2010, 41(8): e519-536. doi: 10.1161/STROKEAHA.110.581975.
[2] Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2012, 43(6): 1711-1737.
[3] Rinkel GJ, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage[J]. Lancet Neurol, 2011, 10(4): 349-356.
[4] Zhao B, Fan Y, Xiong Y, et al. Aneurysm rebleeding after poor-grade aneurysmal subarachnoid hemorrhage: Predictors and impact on clinical outcomes[J]. Neurol Sci, 2016, 371: 62-66. doi:10.1016/j.jns.2016.10.020.
[5] Germans MR, Coert BA, Vandertop WP, et al. Time intervals from subarachnoid hemorrhage to rebleed[J]. Neurol, 2014, 261(7): 1425-1431.
[6] Wu TC, Tsui YK, Chen TY, et al. Rebleeding of aneurysmal subarachnoid hemorrhage in computed tomography angiography: risk factor, rebleeding pattern, and outcome analysis[J]. J Comput Assist Tomogr, 2012, 36(1): 103-108.
[7] Starke RM, Connolly ES Jr. Participants in the international multi-disciplinary consensus conference on the critical care management of subarachnoid hemorrhage. rebleeding after aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2011, 5(2): 241-246.
[8] Osgood ML. Aneurysmal subarachnoid hemorrhage: review of the pathophysiology and management strategies[J]. Curr Neurol Neurosci Rep, 2021, 21(9): 50.
[9] Guo LM, Zhou HY, Xu JW, et al. Risk factors related to aneurismal rebleeding[J]. World Neurosurg, 2011, 76(3-4): 292-298.
[10] De Marchis GM, Lantigua H, Schmidt JM, et al. Impact of premorbid hypertension on haemorrhage severity and aneurysm rebleeding risk after subarachnoid haemorrhage[J]. J Neurol Neurosurg Psychiatry, 2014, 85(1): 56-59.
[11] Koopman I, Greving JP, van der Schaaf IC, et al. Aneurysm characteristics and risk of rebleeding after subarachnoid haemorrhage[J]. Eur Stroke J, 2019, 4(2): 153-159.
[12] Cha KC, Kim JH, Kang HI, et al. Aneurysmal rebleeding: factors associated with clinical outcome in the rebleeding patients[J]. J Korean Neurosurg Soc, 2010, 47(2): 119-123.
[13] Cagnazzo F, Gambacciani C, Morganti R, et al. Aneurysm rebleeding after placement of external ventricular drainage: a systematic review and meta-analysis[J]. Acta Neurochir(Wien), 2017, 159(4): 695-704.
[14] Cong W, Zhongxin Z, Tiangui L, et al. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage based on the analysis of on-admission information[J]. Turk Neurosurg, 2012, 22(6): 675-681.
[15] Linzey JR, Williamson C, Rajajee V, et al. Twenty-four-hour emergency intervention versus early intervention in aneurysmal subarachnoid hemorrhage[J]. J Neurosurg, 2018, 128(5): 1297-1303.
[16] Roelz R, Grauvogel J, Csok I, et al. Patterns of intracerebral hemorrhage that result in unfavorable outcomes in patients with subarachnoid hemorrhage[J]. Clin Neurol Neurosurg, 2021, 205: 106603. doi: 10.1016/j.clineuro.2021.106603.
[17] Cooper JG, Smith B, Hassan TB. A retrospective review of sudden onset severe headache and subarachnoid haemorrhage on the clinical decision unit: looking for a needle in a haystack[J]. Eur J Emerg Med, 2016, 23(5): 356-362.
[18] Huang AP, Arora S, Wintermark M, et al. Perfusion computed tomographic imaging and surgical selection with patients after poor-grade aneurysmal subarachnoid hemorrhage[J]. Neurosurgery, 2010, 67(4): 964-974.
[19] 王立江, 段传志, 何旭英, 等. 血管内栓塞治疗颅内小动脉瘤性蛛网膜下腔出血预后的研究[J]. 山东大学学报(医学版), 2010, 48(2): 94-100. WANG Lijiang, DUAN Chuanzhi, HE Xuying, et al. Prognosis of subarachnoid hemorrhage due to small ruptured intracranial aneurysms treated by guglielmi detachable coils endovascular embolization[J]. Journal of Shandong University(Health Sciences), 2010, 48(2): 94-100.
[20] Sandström N, Yan B, Dowling R, et al. Comparison of microsurgery and endovascular treatment on clinical outcome following poor-grade subarachnoid hemorrhage[J]. J Clin Neurosci, 2013, 20(9): 1213-1218.
[21] Tang C, Zhang TS, Zhou LF. Risk factors for rebleeding of aneurysmal subarachnoid haemorrhage: a meta-analysis[J]. PLoS One, 2014, 9(6): e99536. doi: 10.1371/journal.pone.0099536.
[22] Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association[J]. Stroke, 2009, 40(3): 994-1025.
[23] Szklener S, Melges A, Korchut A, et al. Predictive model for patients with poor-grade subarachnoid haemorrhage in 30-day observation: a 9-year cohort study[J]. BMJ Open, 2015, 5(6): e007795. doi: 10.1136/bmjopen-2015-007795.
[24] Viarasilpa T, Ghosh P, Gidwani S, et al. Prognostic significance of sentinel headache preceding aneurysmal subarachnoid hemorrhage[J]. World Neurosurg, 2020, 139: e672-e676. doi: 10.1016/j.wneu.2020.04.097.

相关文章 15

[1]	孙佳丽,王亮,王长凤,张杰,郭磊. Klippel-Trenaunay综合征儿童情绪与行为特征及其影响因素[J]. 山东大学学报 (医学版), 2026, 64(3): 78-82.
[2]	宋一鸣,王佳丰,韩晓娟,杜怡峰. 脑维持与认知功能:测量、影响因素和机制[J]. 山东大学学报 (医学版), 2026, 64(1): 1-7.
[3]	徐欣颖,颜伟,石兴龙,岳芳,吕婧,乔颖异,张宇琦,程传龙,左慧,李秀君. 山东省滨州市手足口病的流行特征及影响因素[J]. 山东大学学报 (医学版), 2026, 64(1): 118-125.
[4]	孙爽爽,仉率杰,张伯韬,袁莹,于媛媛,薛付忠. 基于真实世界研究的18~50岁人群急性缺血性卒中影响因素[J]. 山东大学学报 (医学版), 2025, 63(9): 40-46.
[5]	王宁,郝秀梅,牛翔,黄金明,徐静雅. 中国中老年高血糖、血脂异常、高血压人群健康体检服务利用现状及影响因素[J]. 山东大学学报 (医学版), 2025, 63(7): 82-91.
[6]	张永媛,王清亮,连雪洪. 山东省某三级综合医院罕见病患者住院费用结构变动情况及影响因素[J]. 山东大学学报 (医学版), 2025, 63(5): 111-119.
[7]	陈瑛翼,游倩,王意,张帆,李凤,季舒铭,徐浩源,饶志勇. 办公室职员肌肉质量减少预测模型的开发与验证[J]. 山东大学学报 (医学版), 2025, 63(4): 26-35.
[8]	刘国伟,翟艳,王薇,吕军城. 潍坊市某城区65岁及以上老年人社会适应能力现状及其影响因素[J]. 山东大学学报 (医学版), 2025, 63(2): 104-110.
[9]	穆弘杰,卢伟,吕军城. 居民抑郁、焦虑症状和心理健康素养现况及影响因素分析[J]. 山东大学学报 (医学版), 2025, 63(12): 105-111.
[10]	刘峰,马彩霞,李春燕,程海英,靳乐雨,刘仲,李学文. 2023年11月流感高峰期济南市大学生流感样病例发生情况及影响因素[J]. 山东大学学报 (医学版), 2024, 62(7): 91-97.
[11]	景睿,张文茜,董卉,董怡然,于胜男,段勇,闫芹,赵传禄,李秀君,汪卫兵. 济南市大一新生结核病防治知信行现状及行为影响因素[J]. 山东大学学报 (医学版), 2024, 62(2): 101-107.
[12]	冯绪强,高萍,孙超,陶琳,闫根全,冷冰. 替加环素治疗感染性疾病临床疗效及影响因素[J]. 山东大学学报 (医学版), 2024, 62(12): 11-20.
[13]	于菲萍,李鑫,司明舒,张丹,苏永刚. 医学生医养结合认知程度与养老就业意愿[J]. 山东大学学报 (医学版), 2024, 62(11): 105-114.
[14]	刘凤祺,高峰,薛彩彩,乔秀梅,王金红. 高糖诱导PC12细胞损伤的影响因素及梓醇的保护作用[J]. 山东大学学报 (医学版), 2023, 61(7): 34-39.
[15]	程传龙,韩闯,房启迪,刘盈,杨淑霞,崔峰,刘靖靖,李秀君. 基于时空地理加权回归模型探索肺癌发病的环境影响因素[J]. 山东大学学报 (医学版), 2023, 61(4): 95-102.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed